Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

<p>Abstract</p> <p>Background</p> <p>Fibrates have been reported to cause paradoxical decreases in HDL-C in certain patients.</p> <p>Design and methods</p> <p>This post-hoc analysis explored the frequency/magnitude of HDL-C reductions in a pooled...

Full description

Bibliographic Details
Main Authors: Farnier Michel, Dong Qian, Shah Arvind, Johnson-Levonas Amy O, Brudi Philippe
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Lipids in Health and Disease
Subjects:
high-density lipoprotein cholesterol
fibrates
dyslipidemia
ezetimibe
simvastatin
Online Access:http://www.lipidworld.com/content/10/1/212

Internet

http://www.lipidworld.com/content/10/1/212

Similar Items